Assessment of AD-relevant phenotypes showed that the effects of the APP/PS1 transgenes are strain-dependent and sex-dependent, with significant differences in amyloid deposition, neuronal cell loss and cerebral amyloid angiopathy (CAA). The gene discussed is PSEN1; the disease is Alzheimer disease.